Sickle cell disease: a chronic inflammatory condition
- PMID: 11421623
- DOI: 10.1054/mehy.2000.1310
Sickle cell disease: a chronic inflammatory condition
Abstract
Homozygous sickle cell disease (SCD) has a wide spectrum of clinical manifestations which varies from an almost asymptomatic condition to severe illness, despite the fact that all subjects with this disease have the same base change in their DNA. The source of this variation is partly environmental, but a large part of this variability can derive from the presence of genetic modulators which are not fully understood. It was postulated that some degree of immunodeficiency should be associated with this condition, but no deficiency, directly related to a given component of the immune system, was observed that could explain the high levels of recurrent infections presented by sickle cell disease patients. Reviewing data from the literature we suggest that the influence of the immune system in the variation of clinical manifestations presented by SCD patients is not related with any immunodeficiency but is rather the result of a chronic inflammatory condition.
Copyright 2001 Harcourt Publishers Ltd.
Similar articles
-
Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.Blood Cells Mol Dis. 2009 Jan-Feb;42(1):25-31. doi: 10.1016/j.bcmd.2008.08.003. Epub 2008 Oct 26. Blood Cells Mol Dis. 2009. PMID: 18954999 Clinical Trial.
-
The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.Pediatr Hematol Oncol. 2003 Sep;20(6):429-34. Pediatr Hematol Oncol. 2003. PMID: 14631615
-
Leukotriene pathway in sickle cell disease: a potential target for directed therapy.Expert Rev Hematol. 2009 Feb;2(1):57-68. doi: 10.1586/17474086.2.1.57. Expert Rev Hematol. 2009. PMID: 21082995 Review.
-
[The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].Arch Pediatr. 2008 Jan;15(1):24-8. doi: 10.1016/j.arcped.2007.09.013. Epub 2007 Dec 31. Arch Pediatr. 2008. PMID: 18164913 French.
-
Hydroxyurea for children with sickle cell disease.Pediatr Clin North Am. 2008 Apr;55(2):483-501, x. doi: 10.1016/j.pcl.2008.02.003. Pediatr Clin North Am. 2008. PMID: 18381097 Review.
Cited by
-
[Hematological and nutritional profile of homozygous sickle cell SS aged 6 to 59 months in Lubumbashi, Democratic Republic of Congo].Pan Afr Med J. 2015 Aug 11;21:276. doi: 10.11604/pamj.2015.21.276.6363. eCollection 2015. Pan Afr Med J. 2015. PMID: 26587126 Free PMC article. French.
-
[Evaluation of hemogram in patients with homozygous sickle cell disease: about 87 cases].Pan Afr Med J. 2016 Dec 20;25:240. doi: 10.11604/pamj.2016.25.240.11118. eCollection 2016. Pan Afr Med J. 2016. PMID: 28293356 Free PMC article. French.
-
CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.Front Immunol. 2021 Dec 10;12:758358. doi: 10.3389/fimmu.2021.758358. eCollection 2021. Front Immunol. 2021. PMID: 34956188 Free PMC article. Review.
-
Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.Blood. 2016 Jan 28;127(4):473-86. doi: 10.1182/blood-2015-08-663245. Epub 2015 Dec 16. Blood. 2016. PMID: 26675351 Free PMC article.
-
Histopathology of experimentally induced asthma in a murine model of sickle cell disease.Blood. 2008 Sep 15;112(6):2529-38. doi: 10.1182/blood-2008-01-132506. Epub 2008 Jun 25. Blood. 2008. PMID: 18579795 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical